Moukheibir Catherine

Moukheibir Catherine is listed in filings as Director at MoonLake Immunotherapeutics. This profile follows SEC Form 4 activity through Jul 7, 2025, including sale activity. Recent filings connect the profile to MoonLake Immunotherapeutics (MLTX) and Ironwood Pharmaceuticals, Inc. (IRWD). The current snapshot covers public activity from Jun 21, 2024 to Jul 7, 2025. Reported amounts are shown as $326.3K to $287.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.